Disc Medicine, Inc.(IRON)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
IRON Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Disc Medicine, Inc. (IRON), a Healthcare sector company. IRON is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Disc Medicine, Inc. reports net income of $-63.5M, free cash flow of $-62.2M. Top institutional holders of IRON by reported 13-F value include FMR, RA CAPITAL MANAGEMENT, L.P., BlackRock,, based on the most recent SEC filings. IRON trades on the Nasdaq exchange and files with the SEC under CIK 1816736. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRON daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Disc Medicine, Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-63.5M
Free Cash Flow
Q1 2026
$-62.2M
D/E Ratio
Q1 2026
0.04
Get alerted when IRON's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Disc Medicine, Inc. including:
Top Institutional Holders of IRON
FMR LLC
$357.2M5,586,894 shRA CAPITAL MANAGEMENT, L.P.
$156.7M2,450,221 shBlackRock, Inc.
$145.4M2,273,831 shWELLINGTON MANAGEMENT GROUP LLP
$111.0M1,735,376 shSTATE STREET CORP
$108.6M1,698,244 shAtlas Venture Life Science Advisors, LLC
$96.8M1,513,875 shVANGUARD CAPITAL MANAGEMENT LLC
$87.9M1,375,430 shFrazier Life Sciences Management, L.P.
$86.6M1,354,852 shTCG Crossover Management, LLC
$85.8M1,341,862 shBVF INC/IL
$81.4M1,272,312 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $357.2M | 5,586,894 |
| RA CAPITAL MANAGEMENT, L.P. | $156.7M | 2,450,221 |
| BlackRock, Inc. | $145.4M | 2,273,831 |
| WELLINGTON MANAGEMENT GROUP LLP | $111.0M | 1,735,376 |
| STATE STREET CORP | $108.6M | 1,698,244 |
| Atlas Venture Life Science Advisors, LLC | $96.8M | 1,513,875 |
| VANGUARD CAPITAL MANAGEMENT LLC | $87.9M | 1,375,430 |
| Frazier Life Sciences Management, L.P. | $86.6M | 1,354,852 |
| TCG Crossover Management, LLC | $85.8M | 1,341,862 |
| BVF INC/IL | $81.4M | 1,272,312 |
More Healthcare Companies
View all Healthcare →Put IRON on your watchlist
Track score changes the day Disc Medicine, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IRON a good stock to buy?
13F Pro's AI-powered analysis of Disc Medicine, Inc. (IRON) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IRON are available on the IRON stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own IRON?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IRON. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Disc Medicine, Inc.'s investment landscape.